These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The vaccine adjuvant alum inhibits IL-12 by promoting PI3 kinase signaling while chitosan does not inhibit IL-12 and enhances Th1 and Th17 responses. Mori A; Oleszycka E; Sharp FA; Coleman M; Ozasa Y; Singh M; O'Hagan DT; Tajber L; Corrigan OI; McNeela EA; Lavelle EC Eur J Immunol; 2012 Oct; 42(10):2709-19. PubMed ID: 22777876 [TBL] [Abstract][Full Text] [Related]
3. In interleukin-4-deficient mice, alum not only generates T helper 1 responses equivalent to freund's complete adjuvant, but continues to induce T helper 2 cytokine production. Brewer JM; Conacher M; Satoskar A; Bluethmann H; Alexander J Eur J Immunol; 1996 Sep; 26(9):2062-6. PubMed ID: 8814247 [TBL] [Abstract][Full Text] [Related]
4. Interleukin-10-treated dendritic cells do not inhibit Th2 immune responses in ovalbumin/alum-sensitized mice. Bellinghausen I; Sudowe S; König B; Reske-Kunz AB; Knop J; Saloga J Int Arch Allergy Immunol; 2006; 141(1):61-9. PubMed ID: 16804328 [TBL] [Abstract][Full Text] [Related]
5. OVA-bound nanoparticles induce OVA-specific IgG1, IgG2a, and IgG2b responses with low IgE synthesis. Yanase N; Toyota H; Hata K; Yagyu S; Seki T; Harada M; Kato Y; Mizuguchi J Vaccine; 2014 Oct; 32(45):5918-24. PubMed ID: 25211769 [TBL] [Abstract][Full Text] [Related]
6. Improving the Th1 cellular efficacy of the lead Yersinia pestis rF1-V subunit vaccine using SA-4-1BBL as a novel adjuvant. Dinc G; Pennington JM; Yolcu ES; Lawrenz MB; Shirwan H Vaccine; 2014 Sep; 32(39):5035-40. PubMed ID: 25045812 [TBL] [Abstract][Full Text] [Related]
7. Naltrexone; as an efficient adjuvant in induction of Th1 immunity and protection against Fasciola hepatica infection. Azizi H; Mirzaeei H; Nasiri AA; Bazi A; Mirzapour A; Khatami M; Nahavandi KH; Azimi A; Yaghoobi H Exp Parasitol; 2018 Jun; 189():66-71. PubMed ID: 29729492 [TBL] [Abstract][Full Text] [Related]
8. RLJ-NE-299A: a new plant based vaccine adjuvant. Khajuria A; Gupta A; Singh S; Malik F; Singh J; Suri KA; Satti NK; Qazi GN; Srinivas VK; Gopinathan ; Ella K Vaccine; 2007 Mar; 25(14):2706-15. PubMed ID: 16872726 [TBL] [Abstract][Full Text] [Related]
9. Relative contribution of Th1 and Th17 cells in adaptive immunity to Bordetella pertussis: towards the rational design of an improved acellular pertussis vaccine. Ross PJ; Sutton CE; Higgins S; Allen AC; Walsh K; Misiak A; Lavelle EC; McLoughlin RM; Mills KH PLoS Pathog; 2013; 9(4):e1003264. PubMed ID: 23592988 [TBL] [Abstract][Full Text] [Related]
10. A CpG-containing oligodeoxynucleotide as an efficient adjuvant counterbalancing the Th1/Th2 immune response in diphtheria-tetanus-pertussis vaccine. Sugai T; Mori M; Nakazawa M; Ichino M; Naruto T; Kobayashi N; Kobayashi Y; Minami M; Yokota S Vaccine; 2005 Nov; 23(46-47):5450-6. PubMed ID: 16006019 [TBL] [Abstract][Full Text] [Related]
12. Interleukin-4- and NACHT, LRR and PYD domains-containing protein 3-independent mechanisms of alum enhanced T helper type 2 responses on basophils. Huang FJ; Ma YL; Tang RY; Gong WC; Li J; Chen CX; Yin L; Chen XP Immunology; 2016 Oct; 149(2):238-51. PubMed ID: 27315109 [TBL] [Abstract][Full Text] [Related]
13. Suppression of endogenous IL-10 gene expression in dendritic cells enhances antigen presentation for specific Th1 induction: potential for cellular vaccine development. Igietseme JU; Ananaba GA; Bolier J; Bowers S; Moore T; Belay T; Eko FO; Lyn D; Black CM J Immunol; 2000 Apr; 164(8):4212-9. PubMed ID: 10754317 [TBL] [Abstract][Full Text] [Related]
14. Vaccination with toxofilin DNA in combination with an alum-monophosphoryl lipid A mixed adjuvant induces significant protective immunity against Toxoplasma gondii. Song P; He S; Zhou A; Lv G; Guo J; Zhou J; Han Y; Zhou H; Hao Z; Cong H BMC Infect Dis; 2017 Jan; 17(1):19. PubMed ID: 28056837 [TBL] [Abstract][Full Text] [Related]
15. Whole recombinant Hansenula polymorpha expressing hepatitis B virus surface antigen (yeast-HBsAg) induces potent HBsAg-specific Th1 and Th2 immune responses. Bian G; Cheng Y; Wang Z; Hu Y; Zhang X; Wu M; Chen Z; Shi B; Sun S; Shen Y; Chen EJ; Yao X; Wen Y; Yuan Z Vaccine; 2009 Dec; 28(1):187-94. PubMed ID: 19789093 [TBL] [Abstract][Full Text] [Related]
16. IL-1α and inflammasome-independent IL-1β promote neutrophil infiltration following alum vaccination. Oleszycka E; Moran HB; Tynan GA; Hearnden CH; Coutts G; Campbell M; Allan SM; Scott CJ; Lavelle EC FEBS J; 2016 Jan; 283(1):9-24. PubMed ID: 26536497 [TBL] [Abstract][Full Text] [Related]
17. Platycodin D is a potent adjuvant of specific cellular and humoral immune responses against recombinant hepatitis B antigen. Xie Y; Sun HX; Li D Vaccine; 2009 Jan; 27(5):757-64. PubMed ID: 19041358 [TBL] [Abstract][Full Text] [Related]
18. Naloxone and alum synergistically augment adjuvant activities of each other in a mouse vaccine model of Salmonella typhimurium infection. Jazani NH; Parsania S; Sohrabpour M; Mazloomi E; Karimzad M; Shahabi S Immunobiology; 2011 Jun; 216(6):744-51. PubMed ID: 21093956 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of elastase enhances the adjuvanticity of alum and promotes anti-SARS-CoV-2 systemic and mucosal immunity. Kim E; Attia Z; Woodfint RM; Zeng C; Kim SH; Steiner HE; Shukla RK; Liyanage NPM; Ghimire S; Li J; Renukaradhya GJ; Satoskar AR; Amer AO; Liu SL; Cormet-Boyaka E; Boyaka PN Proc Natl Acad Sci U S A; 2021 Aug; 118(34):. PubMed ID: 34353890 [TBL] [Abstract][Full Text] [Related]
20. Dectin-1 activation unlocks IL12A expression and reveals the TH1 potency of neonatal dendritic cells. Lemoine S; Jaron B; Tabka S; Ettreiki C; Deriaud E; Zhivaki D; Le Ray C; Launay O; Majlessi L; Tissieres P; Leclerc C; Lo-Man R J Allergy Clin Immunol; 2015 Nov; 136(5):1355-68.e1-15. PubMed ID: 25865351 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]